Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2019; Volume 60,Issue 3

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 6A;

Leadership Perspectives

  • You have access
    Discussions with Leaders: A Conversation between Simon Cherry and Johannes Czernin
    Simon R. Cherry and Johannes Czernin
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 295-298;

The State of the Art

  • You have access
    First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
    Ramsey D. Badawi, Hongcheng Shi, Pengcheng Hu, Shuguang Chen, Tianyi Xu, Patricia M. Price, Yu Ding, Benjamin A. Spencer, Lorenzo Nardo, Weiping Liu, Jun Bao, Terry Jones, Hongdi Li and Simon R. Cherry
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 299-303; DOI: https://doi.org/10.2967/jnumed.119.226498

Continuing Education

  • You have access
    An Imager’s Guide to Perineural Tumor Spread in Head and Neck Cancers: Radiologic Footprints on 18F-FDG PET, with CT and MRI Correlates
    Hwan Lee, Jillian W. Lazor, Reza Assadsangabi and Jagruti Shah
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 304-311; DOI: https://doi.org/10.2967/jnumed.118.214312

Clinical

  • Oncology

    • You have access
      Evaluation of 11C-Methionine PET and Anatomic MRI Associations in Diffuse Intrinsic Pontine Glioma
      Christopher L. Tinkle, Elizabeth C. Duncan, Mikhail Doubrovin, Yuanyuan Han, Yimei Li, Hyun Kim, Alberto Broniscer, Scott E. Snyder, Thomas E. Merchant and Barry L. Shulkin
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 312-319; DOI: https://doi.org/10.2967/jnumed.118.212514
    • INVITED PERSPECTIVE

      • You have access
        Practical Methods for Estimating Metabolic Flux (Ki) to Assess Response to Therapy via Static PET Scans
        Robert K. Doot
        Journal of Nuclear Medicine March 1, 2019, 60 (3) 320-321; DOI: https://doi.org/10.2967/jnumed.118.220913
    • Open Access
      Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?
      Gurdip K. Azad, Musib Siddique, Benjamin Taylor, Adrian Green, Jim O’Doherty, Joanna Gariani, Glen M. Blake, Janine Mansi, Vicky Goh and Gary J.R. Cook
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 322-327; DOI: https://doi.org/10.2967/jnumed.118.208710
    • You have access
      What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
      Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball and Michael P. Mac Manus
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 328-334; DOI: https://doi.org/10.2967/jnumed.118.214148
    • FEATURED ARTICLE OF THE MONTH

      • You have access
        18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
        Kimiteru Ito, Rebecca Teng, Heiko Schöder, John L. Humm, Ai Ni, Laure Michaud, Reiko Nakajima, Rikiya Yamashita, Jedd D. Wolchok and Wolfgang A. Weber
        Journal of Nuclear Medicine March 1, 2019, 60 (3) 335-341; DOI: https://doi.org/10.2967/jnumed.118.213652
    • You have access
      Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions
      Simone Schenke, Philipp Seifert, Michael Zimny, Thomas Winkens, Ina Binse and Rainer Görges
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 342-347; DOI: https://doi.org/10.2967/jnumed.118.211912
    • BRIEF COMMUNICATION

      • You have access
        Hexokinase-2 Expression in 11C-Methionine–Positive, 18F-FDG–Negative Multiple Myeloma
        Stefan Kircher, Antje Stolzenburg, Klaus Martin Kortüm, Malte Kircher, Matteo Da Via, Samuel Samnick, Andreas K. Buck, Hermann Einsele, Andreas Rosenwald and Constantin Lapa
        Journal of Nuclear Medicine March 1, 2019, 60 (3) 348-352; DOI: https://doi.org/10.2967/jnumed.118.217539
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Open Access
        Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
        Thomas A. Burley, Chiara Da Pieve, Carlos D. Martins, Daniela M. Ciobota, Louis Allott, Wim J.G Oyen, Kevin J. Harrington, Graham Smith and Gabriela Kramer-Marek
        Journal of Nuclear Medicine March 1, 2019, 60 (3) 353-361; DOI: https://doi.org/10.2967/jnumed.118.216069

Theranostics

  • Clinical

    • Open Access
      Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
      Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka and Matthias Eiber
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 362-368; DOI: https://doi.org/10.2967/jnumed.118.212233
    • You have access
      Performance of 68Ga-DOTA–Conjugated Somatostatin Receptor–Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis
      Sangwon Han, Chong Hyun Suh, Sungmin Woo, Yeon Joo Kim and Jong Jin Lee
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 369-376; DOI: https://doi.org/10.2967/jnumed.118.211706
    • You have access
      Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
      Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Karin Niepsch, Dirk Müller and Richard P. Baum
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 377-385; DOI: https://doi.org/10.2967/jnumed.118.215848
  • Translational

    • FEATURED ARTICLE OF THE MONTH

      • Open Access
        68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
        Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Manfred M. Marschalek, Anastasia Loktev, Wencke Lehnert, Jürgen Debus, Dirk Jäger, Paul Flechsig, Annette Altmann, Walter Mier and Uwe Haberkorn
        Journal of Nuclear Medicine March 1, 2019, 60 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.118.215913
    • You have access
      Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
      Alexander W. Sauter, Rosalba Mansi, Ulrich Hassiepen, Lionel Muller, Tania Panigada, Stefan Wiehr, Anna-Maria Wild, Susanne Geistlich, Martin Béhé, Christof Rottenburger, Damian Wild and Melpomeni Fani
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 393-399; DOI: https://doi.org/10.2967/jnumed.118.207845
    • You have access
      Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen
      Sangeeta Ray Banerjee, Vivek Kumar, Ala Lisok, Donika Plyku, Zora Nováková, Mary Brummet, Bryan Wharram, Cyril Barinka, Robert Hobbs and Martin G. Pomper
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 400-406; DOI: https://doi.org/10.2967/jnumed.118.214403

Cardiology

  • Clinical

    • INVITED PERSPECTIVE

      • You have access
        Quantitative Coronary Flow Capacity for Risk Stratification and Clinical Decision Making: Is It Ready for Prime Time?
        Marcelo F. Di Carli and Rory Hachamovitch
        Journal of Nuclear Medicine March 1, 2019, 60 (3) 407-409; DOI: https://doi.org/10.2967/jnumed.118.219717
    • Open Access
      Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease
      K. Lance Gould, Nils P. Johnson, Amanda E. Roby, Tung Nguyen, Richard Kirkeeide, Mary Haynie, Dejian Lai, Hongjian Zhu, Monica B. Patel, Richard Smalling, Sal Arain, Prakash Balan, Tom Nguyen, Anthony Estrera, Stefano Sdringola, Mohammad Madjid, Angelo Nascimbene, Pranav Loyalka, Biswajit Kar, Igor Gregoric, Hazem Safi and David McPherson
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.118.211953

Molecular Imaging

  • Translational

    • You have access
      Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
      Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit and Wouter B. Nagengast
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 418-423; DOI: https://doi.org/10.2967/jnumed.118.216556

Radiochemistry

  • Basic

    • You have access
      Production of 15O for Medical Applications via the 16O(γ,n)15O Reaction
      Stacy L. Queern, Ryan Cardman, Christopher S. Loveless, Matthew R. Shepherd and Suzanne E. Lapi
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 424-428; DOI: https://doi.org/10.2967/jnumed.118.215681

Physics and Instrumentation

  • You have access
    Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction
    Angel Torrado-Carvajal, Javier Vera-Olmos, David Izquierdo-Garcia, Onofrio A. Catalano, Manuel A. Morales, Justin Margolin, Andrea Soricelli, Marco Salvatore, Norberto Malpica and Ciprian Catana
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 429-435; DOI: https://doi.org/10.2967/jnumed.118.209288

Letters to the Editor

  • You have access
    Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells
    Jörg Kotzerke, Roswitha Runge, Anja Braune and Gerd Wunderlich
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 436; DOI: https://doi.org/10.2967/jnumed.118.220707
  • You have access
    Reply: Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells
    Orit Jacobson and Xiaoyuan Chen
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 436-437; DOI: https://doi.org/10.2967/jnumed.118.223453
  • You have access
    Reply: Radiation Dose Does Matter: Mechanistic Insights into DNA Damage and Repair Support the Linear No-Threshold Model of Low-Dose Radiation Health Risks
    James R. Duncan, Michael R. Lieber, Noritaka Adachi and Richard L. Wahl
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 437-438; DOI: https://doi.org/10.2967/jnumed.118.223461

Erratum

  • You have access
    Erratum
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 438;

SNMMI Newsline

  • You have access
    News: FDA Reviews NDA for 18F-FDOPA in Congenital Hyperinsulinism
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 7N;
  • You have access
    News: SNMMI and SNMMI-TS 2019 Leadership Graduates
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 8N;
  • You have access
    News from SNMMI Leadership: Thought Leaders to Gather at 2019 SNMMI Annual Meeting in Anaheim, CA
    Virginia Pappas
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 9N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 10N-15N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (3)
Journal of Nuclear Medicine
Vol. 60, Issue 3
March 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
  • 18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
  • Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
  • First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
Sign up for alerts

Jump to

  • This Month in JNM
  • Leadership Perspectives
  • The State of the Art
  • Continuing Education
  • Clinical
    • Oncology
      • INVITED PERSPECTIVE
      • FEATURED ARTICLE OF THE MONTH
      • BRIEF COMMUNICATION
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Theranostics
    • Clinical
    • Translational
      • FEATURED ARTICLE OF THE MONTH
  • Cardiology
    • Clinical
      • INVITED PERSPECTIVE
  • Molecular Imaging
    • Translational
  • Radiochemistry
    • Basic
  • Physics and Instrumentation
  • Letters to the Editor
  • Erratum
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire